Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies

US8012470B2 · kind B2 · utility

Assignee

• Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · DE

Inventors

• Horst Lindhofer · Puchheim, DE
• Hans-Joachim Kolb · Wetter, DE
• Reinhard Zeidler · Birkenfeld, DE
• Georg Bornkamm · Hersbruck, DE

Key dates

• Filing date: Jul 20, 2005
• Grant date: Sep 6, 2011
• Expiry date: May 8, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

According to the invention there is described a method for ex vivo immunization of humans and animals comprising the following steps of: